Business Description
![Pulse Biosciences Inc Pulse Biosciences Inc logo](https://static.gurufocus.com/logos/0C0000B1P2.png?14)
Pulse Biosciences Inc
NAICS : 339113
SIC : 3841
ISIN : US74587B1017
Description
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled. Substantial revenue is generated from North America Majorly due to the sale of systems.
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 3.92 | |||||
Equity-to-Asset | 0.74 | |||||
Debt-to-Equity | 0.25 | |||||
Debt-to-EBITDA | -0.21 | |||||
Interest Coverage | N/A |
N/A
|
N/A
| |||
Piotroski F-Score | 4/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 25.1 | |||||
3-Year EPS without NRI Growth Rate | 25.6 | |||||
3-Year FCF Growth Rate | 23.5 | |||||
3-Year Book Growth Rate | -3.5 |
Momentum Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 56.04 | |||||
9-Day RSI | 59.96 | |||||
14-Day RSI | 61.12 | |||||
6-1 Month Momentum % | 19 | |||||
12-1 Month Momentum % | 42.8 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 7.06 | |||||
Quick Ratio | 7.06 | |||||
Cash Ratio | 6.87 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -29.2 | |||||
Shareholder Yield % | 4.68 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -116.49 | |||||
ROA % | -66.64 | |||||
ROIC % | -252.41 | |||||
ROC (Joel Greenblatt) % | -490.44 | |||||
ROCE % | -77.1 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 26.26 | |||||
Price-to-Tangible-Book | 29.75 | |||||
EV-to-EBIT | -23.41 | |||||
EV-to-EBITDA | -24.06 | |||||
EV-to-Forward-Revenue | 7.94 | |||||
EV-to-FCF | -28.75 | |||||
Price-to-Net-Current-Asset-Value | 41.37 | |||||
Price-to-Net-Cash | 43.49 | |||||
Earnings Yield (Greenblatt) % | -4.27 | |||||
FCF Yield % | -3.48 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:PLSE
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Pulse Biosciences Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | |||
EPS (TTM) ($) | -0.796 | ||
Beta | 2 | ||
Volatility % | 136.13 | ||
14-Day RSI | 61.12 | ||
14-Day ATR ($) | 1.678059 | ||
20-Day SMA ($) | 15.275 | ||
12-1 Month Momentum % | 42.8 | ||
52-Week Range ($) | 3.716982 - 20.4382 | ||
Shares Outstanding (Mil) | 61.23 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Pulse Biosciences Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Pulse Biosciences Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Pulse Biosciences Inc Frequently Asked Questions
What is Pulse Biosciences Inc(PLSE)'s stock price today?
The current price of PLSE is $16.96. The 52 week high of PLSE is $20.44 and 52 week low is $3.72.
When is next earnings date of Pulse Biosciences Inc(PLSE)?
The next earnings date of Pulse Biosciences Inc(PLSE) is 2024-08-09 Est..
Does Pulse Biosciences Inc(PLSE) pay dividends? If so, how much?
Pulse Biosciences Inc(PLSE) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |